Y-Intercept (HK)’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-235,192	Closed	-$287K	–	1759
2025 Q1	$287K	Buy	+235,192	New	+$287K	0.02%	921
2024 Q2	–	Sell	-11,140	Closed	-$26.6K	–	1558
2024 Q1	$26.6K	Buy	+11,140	New	+$26.6K	﹤0.01%	1312